Watch the webcast!The 2013 meeting of the highly successful International Workshop on Co-morbidities & Adverse Drug Reactions in HIV.
2014 Subscriptions availableOrder the next volume of Antiviral Therapy today.
Follow us on TwitterInternational Medical Press is now on Twitter. Join our conversation today.
Editors-in-Chief: Douglas D Richman & Joep MA Lange
Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2012 ISI impact factor: 3.07).
The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.
♦ Immediate online publication
♦ A leading Editorial Board ensuring high-quality standards
♦ Worldwide readership
♦ Inclusion in major indexing and abstracting services
♦ No page charges
HCV is a major global health problem and an important cause of mortality in HIV-coinfected patients. Telaprevir has been approved for the treatment of HCV and its investigation in coinfected patients is ongoing. van Heeswijk et al. review studies looking at the interaction of telaprevir with various antiretrovirals. Read more here.
The Editorial Office welcomes queries about publishing supplements within the journal. Please visit the Supplements page for more information.
ISSN: 1359-6535 (print); 2040-2058 (online)